Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating Activities:
Net income (loss)	$ 1,130	$ 29,181	$ (2,137)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Provision for loan losses	2,476	8,507	64,154
Depreciation, amortization and net loss on sales and revaluations of fixed assets	4,220	3,926	3,968
Recognized impairment charge on securities available for sale	1,240	528	368
Realized gain on security transactions net			(21)
Amortization of premiums on securities, net	1,735	2,067	3,738
Realized (gain) loss on sale and revaluation of OREO	(17)	15	(82)
Increase in cash value of bank owned life insurance	(1,703)	(1,430)	(1,260)
Amortization of other intangible assets	190	748	803
Share-based payment expense	1,365	381	161
Recognized impairment charge on goodwill	18,700
Realized gain on sale of loans held-for-sale		(15,935)
Deferred tax (benefit) expense	(8,995)	1,928	5,068
Decrease in deferred loan fees, net	(3,790)	(1,452)	(252)
Decrease (increase) in accrued interest and other receivables	10,163	15,579	(24,009)
Decrease in other assets	2,597	3,959	2,618
Excess tax benefits from share-based payment arrangements	(166)	(38)	(36)
Increase in accrued interest and other liabilities	1,834	3,501	4,649
Net Cash Provided by Operating Activities	30,979	51,465	57,730
Investing Activities:
Net (increase) decrease in short term investments	(7,883)	(2,826)	55,646
Decrease (increase) in FHLB stock	1,348	(995)	3,179
Proceeds from maturities of securities available for sale	181,732	249,065	215,651
Proceeds from maturities of securities held to maturity	3,999	2,685	3,364
Proceeds from sales of securities available for sale	789	9,997	1,298
Purchases of securities available for sale	(292,050)	(202,322)	(284,019)
Proceeds from sales and payments of loans held for sale		487,432	5,506
Net (increase) decrease in loans	(161,788)	93,590	(388,728)
Proceeds from sales of OREO	267	909	11,036
Premiums paid on bank owned life insurance	(264)	(264)	(10,327)
Net sales (purchases) of premises and equipment	4,673	(1,986)	(1,293)
Net Cash (Used In) Provided by Investing Activities	(269,177)	635,285	(388,687)
Financing Activities:
Proceeds from issuance of common stock	1,094	547	1,223
Excess tax benefits from share-based payment arrangements	166	38	36
Net increase in deposits	113,783	94,679	190,870
Cash dividends paid	(4,729)	(14,125)	(12,401)
Repayment of other borrowings	(40)	(38)	(71,285)
Net (decrease) increase in securities sold under repurchase agreements and short-term borrowings	(245)	(18,432)	16,462
Net Cash Provided by Financing Activities	110,029	62,669	124,905
(Decrease) Increase in Cash and Cash Equivalents	(128,169)	749,419	(206,052)
Cash and Cash Equivalents, Beginning of Period	827,523	78,104	284,156
Cash and Cash Equivalents, End of Period	699,354	827,523	78,104
Supplemental Disclosures:
Interest paid	5,565	7,772	11,523
Income tax payments	5,095	969	12,682
Change in unrealized loss on securities available for sale, net of tax	(5,952)	(2,300)	1,096
Issuance of common stock in connection with dividend reinvestment	41
Transfers to other real estate owned			1,100
Transfers from loans held for sale back to loan portfolio	2,317	121	2,305
Transfers to loans held for sale			$ 473,814